KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Return on Sales (2016 - 2025)

Historic Return on Sales for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to 0.18%.

  • Bristol Myers Squibb's Return on Sales rose 800.0% to 0.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 2800.0%. This contributed to the annual value of 0.18% for FY2024, which is 3600.0% down from last year.
  • According to the latest figures from Q3 2025, Bristol Myers Squibb's Return on Sales is 0.18%, which was up 800.0% from 0.11% recorded in Q2 2025.
  • Bristol Myers Squibb's 5-year Return on Sales high stood at 0.22% for Q1 2025, and its period low was 1.0% during Q1 2024.
  • For the 5-year period, Bristol Myers Squibb's Return on Sales averaged around 0.09%, with its median value being 0.14% (2022).
  • In the last 5 years, Bristol Myers Squibb's Return on Sales plummeted by -12000bps in 2024 and then soared by 12200bps in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Return on Sales (Quarter) stood at 0.2% in 2021, then fell by -10bps to 0.18% in 2022, then decreased by -14bps to 0.15% in 2023, then tumbled by -96bps to 0.01% in 2024, then skyrocketed by 2817bps to 0.18% in 2025.
  • Its last three reported values are 0.18% in Q3 2025, 0.11% for Q2 2025, and 0.22% during Q1 2025.